Jeffrey Glassberg

2.1k total citations · 1 hit paper
65 papers, 1.1k citations indexed

About

Jeffrey Glassberg is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jeffrey Glassberg has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Genetics, 37 papers in Hematology and 17 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jeffrey Glassberg's work include Hemoglobinopathies and Related Disorders (57 papers), Iron Metabolism and Disorders (33 papers) and Prenatal Screening and Diagnostics (8 papers). Jeffrey Glassberg is often cited by papers focused on Hemoglobinopathies and Related Disorders (57 papers), Iron Metabolism and Disorders (33 papers) and Prenatal Screening and Diagnostics (8 papers). Jeffrey Glassberg collaborates with scholars based in United States, United Kingdom and Netherlands. Jeffrey Glassberg's co-authors include Michael R. DeBaun, Lynne D. Richardson, Paula Tanabe, Abdullah Kutlar, Allison A. King, Jane S. Hankins, Victor R. Gordeuk, William T. Zempsky, Mohamed O. Seisa and Fouza Yusuf and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Jeffrey Glassberg

59 papers receiving 1.0k citations

Hit Papers

American Society of Hemat... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Glassberg United States 21 884 636 311 97 93 65 1.1k
Patricia L. Kavanagh United States 17 670 0.8× 474 0.7× 358 1.2× 211 2.2× 50 0.5× 38 1.2k
Jeffrey D. Lebensburger United States 17 894 1.0× 717 1.1× 326 1.0× 54 0.6× 23 0.2× 90 1.1k
Susan E. Creary United States 13 583 0.7× 443 0.7× 214 0.7× 67 0.7× 21 0.2× 67 745
Rupa Redding‐Lallinger United States 15 822 0.9× 680 1.1× 295 0.9× 52 0.5× 10 0.1× 25 1.1k
Sarah L. Reeves United States 14 293 0.3× 228 0.4× 138 0.4× 76 0.8× 17 0.2× 48 465
Sapna Oberoi Canada 15 87 0.1× 182 0.3× 311 1.0× 23 0.2× 40 0.4× 62 875
Christina Ullrich United States 20 119 0.1× 157 0.2× 855 2.7× 66 0.7× 73 0.8× 51 1.4k
Michaela K. Farber United States 12 106 0.1× 112 0.2× 363 1.2× 21 0.2× 87 0.9× 69 625
Katy M. Clark United States 14 136 0.2× 312 0.5× 195 0.6× 70 0.7× 3 0.0× 20 828
Mansour M. Qurachi Saudi Arabia 10 103 0.1× 74 0.1× 162 0.5× 120 1.2× 8 0.1× 14 809

Countries citing papers authored by Jeffrey Glassberg

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Glassberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Glassberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Glassberg more than expected).

Fields of papers citing papers by Jeffrey Glassberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Glassberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Glassberg. The network helps show where Jeffrey Glassberg may publish in the future.

Co-authorship network of co-authors of Jeffrey Glassberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Glassberg. A scholar is included among the top collaborators of Jeffrey Glassberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Glassberg. Jeffrey Glassberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahsanuddin, Sofia, et al.. (2025). Preferential Sites of Retinal Capillary Occlusion in Sickle Cell Disease. Investigative Ophthalmology & Visual Science. 66(1). 57–57.
2.
Badawy, Sherif M., Maura M. Kepper, Robert W. Gibson, et al.. (2025). User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease. Pediatric Blood & Cancer. 72(7). e31746–e31746.
4.
Pugh, Norma, Donald Brambilla, Barbara L. Kroner, et al.. (2024). Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry. American Journal of Hematology. 99(5). 900–909. 9 indexed citations
5.
Badawy, Sherif M., Maura M. Kepper, Robert W. Gibson, et al.. (2024). Factors influencing engagement with adherence-enhancing mobile health app in sickle cell disease. SHILAP Revista de lepidopterología. 2(1). 1 indexed citations
6.
Howell, Kristen E., Norma Pugh, Nirmish Shah, et al.. (2023). Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease. HemaSphere. 7(8). e930–e930. 1 indexed citations
7.
Melvin, Cathy L., Sherif M. Badawy, Michael B. Potter, et al.. (2023). Engagement with Incharge App - a Mobile Health Intervention to Improve Adherence to Hydroxyurea Among Individuals with Sickle Cell Disease. Blood. 142(Supplement 1). 1144–1144.
8.
Ahsanuddin, Sofia, et al.. (2023). 3-D OCT imaging of hyalocytes in partial posterior vitreous detachment and vaso-occlusive retinal disease. American Journal of Ophthalmology Case Reports. 30. 101836–101836. 3 indexed citations
9.
Pinhas, Alexander, Justin Migacz, Vincent Sun, et al.. (2022). Insights into Sickle Cell Disease through the Retinal Microvasculature. SHILAP Revista de lepidopterología. 2(4). 100196–100196. 17 indexed citations
10.
Rosen, Richard B., Justin Migacz, Alexander Pinhas, et al.. (2021). Preferential Vulnerability of Capillary Occlusion in Sickle Cell Retinopathy. Investigative Ophthalmology & Visual Science. 62(11). 12–12. 1 indexed citations
11.
Niu, Li, María Teresa Alarcón Herrera, Bian Liu, et al.. (2021). Chronic Conditions and Pediatric Healthcare Utilization during Warm Weather Days in New York City. Journal of Applied Research on Children Informing Policy for Children at Risk. 12(1). 2 indexed citations
12.
Minniti, Caterina P., Ahmar U. Zaidi, Mehdi Nouraie, et al.. (2021). Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection. Blood Advances. 5(1). 207–215. 51 indexed citations
13.
Smeltzer, Matthew P., Kristen E. Howell, Marsha Treadwell, et al.. (2021). Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA. BMJ Open. 11(11). e050880–e050880. 25 indexed citations
14.
Brandow, Amanda M., C. Patrick Carroll, Susan E. Creary, et al.. (2020). American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Advances. 4(12). 2656–2701. 216 indexed citations breakdown →
15.
17.
Glassberg, Jeffrey, Jason Wang, Robyn T. Cohen, Lynne D. Richardson, & Michael R. DeBaun. (2012). Risk Factors for Increased ED Utilization in a Multinational Cohort of Children With Sickle Cell Disease. Academic Emergency Medicine. 19(6). 664–672. 33 indexed citations
18.
Glassberg, Jeffrey. (2011). Evidence-based management of sickle cell disease in the emergency department.. PubMed. 13(8). 1–20; quiz 20. 28 indexed citations
19.
Field, Joshua J., Jeffrey Glassberg, Joanna Howard, et al.. (2008). Longitudinal analysis of pulmonary function in adults with sickle cell disease. American Journal of Hematology. 83(7). 574–576. 28 indexed citations
20.
Glassberg, Jeffrey, et al.. (2006). Painful Episodes in Children With Sickle Cell Disease and Asthma are Temporally Associated With Respiratory Symptoms. Journal of Pediatric Hematology/Oncology. 28(8). 481–485. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026